Jan 09, 2023 - Jan 12, 2023 / 12:30PM GMT
Jem de los Santos -
Good afternoon, everyone. My name is Jem de los Santos, I'm a Vice President in JPMorgan's Healthcare Investment Banking team based in London. Very happy to present Oxford Biomedica. And without further ado, I'll hand it over to Stuart Paynter, the CFO.
Stuart Paynter - Oxford Biomedica plc - CFO, Company Secretary & Director
Thank you very much, and good afternoon to everyone. Thank you for attending on the graveyard shift on a Wednesday afternoon. It's been a really nice conference, and thank you for JPMorgan for hosting and letting us tell our story. So Oxford Biomedica, we're a focused cell and gene therapy CDMO. We've been on this journey from becoming a product company to an innovation at CDMO for a while now. And that journey is now complete. I'm going to take you through the story, a little bit of history and how we're positioned to really make a big splash in the cell and gene therapy market and where we see some of the opportunities for growth. So there are going to be some forward-looking statements.
So here's
Oxford Biomedica PLC at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers